- Home
- LEGN vs CELH Comparison
LEGN vs CELH Comparison
Compare LEGN & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGN | CELH |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 10.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEGN | CELH |
|---|---|---|
| Price | $21.71 | $43.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $69.67 | $64.18 |
| AVG Volume (30 Days) | 2.6M | ★ 6.2M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | $909,045,000.00 | ★ $2,125,838,000.00 |
| Revenue This Year | $68.83 | $83.38 |
| Revenue Next Year | $51.27 | $32.58 |
| P/E Ratio | ★ N/A | $348.79 |
| Revenue Growth | ★ 74.75 | 55.07 |
| 52 Week Low | $22.28 | $21.10 |
| 52 Week High | $45.30 | $66.74 |
Technical Indicators
Market Signals| Indicator | LEGN | CELH |
|---|---|---|
| Relative Strength Index (RSI) | 20.32 | 44.79 |
| Support Level | $26.43 | $43.24 |
| Resistance Level | $28.97 | $45.56 |
| Average True Range (ATR) | 1.29 | 1.72 |
| MACD | -0.45 | 0.86 |
| Stochastic Oscillator | 1.41 | 55.30 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.